Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze ARCT stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ARCT investment potential.

What is ARCT stock price today?

Get real-time ARCT stock price, historical data, and price charts on Financhill. Track ARCT performance with our advanced analysis tools.

Is ARCT a good investment?

Evaluate ARCT investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ARCT stock?

To buy ARCT stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ARCT?

View detailed market capitalization data and company valuation metrics for ARCT on our comprehensive analysis page.

What is the P/E ratio of ARCT?

Use our fundamental analysis tools to view ARCT P/E ratio and compare valuation metrics with industry peers.

What are ARCT earnings?

View ARCT earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Arcturus Therapeutics Holdings, Inc. 10K Form

Sell

ARCT
Arcturus Therapeutics Holdings, Inc.

Last Price:

$6.80

Seasonality Move:

3.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-10	10Q	ARCT/Arcturus Therapeutics Holdings, Inc. Quarterly
2020-05-08	10Q	ARCT/Arcturus Therapeutics Holdings, Inc. Quarterly
2020-03-16	10K	ARCT/Arcturus Therapeutics Holdings, Inc. Annual
2019-11-08	10Q	ARCT/Arcturus Therapeutics Holdings, Inc. Quarterly
2019-08-14	10Q	ARCT/Arcturus Therapeutics Holdings, Inc. Quarterly

Receive ARCT News And Ratings

See the #1 stock for the next 7 days that we like better than ARCT

ARCT Financial Statistics

Sales & Book Value

Annual Sales:	$138.4M
Cash Flow:	$-19.8M
Price / Cash Flow:	76.35
Annual Sales:	$8.25
Price / Book:	0.83

Profitability

EPS (TTM):	-2.46360
Net Income (TTM):	$-66.7M
Gross Margin:	$134.8M
Return on Equity:	-27.98%
Return on Assets:	-20.36%

Arcturus Therapeutics Holdings, Inc. Earnings Forecast

Key Arcturus Therapeutics Holdings, Inc. Financial Ratios

The Gross Profit Margin over the past 5 years for ARCT is 97.44%.
The Selling, General & Administrative Expenses for ARCT have been equal to 38.17% of Gross Profit Margin.
The Research & Development expenses have been 90.10% of Revenue.
The Net Earning history of ARCT is -58.49% of Total Revenues.
Per Share Earnings over the last 14 years have been positive in 6 years.

Arcturus Therapeutics Holdings, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	ARCT
CUSIP:	M1492T
Website:	arcturusrx.com

Debt

Debt-to-Equity Ratio:	0.12
Current Ratio:	7.86
Quick Ratio:	7.68

Price-to-Earnings

Trailing P/E Ratio:	90.09
Forward P/E Ratio:	20.96

ARCT Technical Analysis vs Fundamental Analysis